Abbott Biologicals: Clinical Trials

6 completed. 4 Phase 3, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	4	Completed 4
Phase 2	2	Completed 2

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season Trivalent influenza subunit vaccine Influvac - Prophylaxis of Influenza	Phase 3	Completed	Abbott Biologicals	120	2012-07-01	2012-08-06
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season Trivalent influenza subunit vaccine Influvac - Influenza	Phase 3	Completed	Abbott Biologicals	121	2010-06-01	2011-08-26
Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine Influenza Vaccine - Influenza	Phase 3	Completed	Abbott Biologicals	3138	2010-01-01	2011-08-26
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Influenza Vaccine - Influenza Vaccines	Phase 2	Completed	Abbott Biologicals	622	2009-11-01	2011-10-27
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season Trivalent influenza subunit vaccine Influvac - Influenza	Phase 3	Completed	Abbott Biologicals	120	2009-06-01	2011-08-26
Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination Cell-Derived Trivalent Subunit Influenza Vaccine, Placebo - Influenza	Phase 2	Completed	Abbott Biologicals	1270	2009-05-01	2013-10-25

Germany (3) · Belgium (2) · Australia (1) · Czechia (1) · Estonia (1) · Lithuania (1) · New Zealand (1) · United States (1)

2009 (2)